Sugammadex Injection, Solution
Product Images NDC 25021-619

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 25021-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Sug02 0000 01)

Chemical structure of Sugammadex Sodium shown as a detailed molecular diagram with multiple sugar rings, sodium ions, and sulfur atoms connected in a cyclic arrangement.*

FDA Label Image

Structural Formula (Sug02 0000 02)

Chemical structure of Sugammadex Sodium depicted as a complex cyclic molecular formula with multiple hydroxyl groups and sodium carboxylate substituents, illustrating its detailed molecular connectivity.*

FDA Label Image

Figure (Sug02 0000 03)

A line graph showing the cumulative recovery rate over time (in minutes) for three treatments: sugammadex 2 mg/kg, rocuronium plus, and neostigmine 0.05 mg/kg. The x-axis represents time to recovery in minutes, and the y-axis shows the cumulative recovery rate. A legend identifies the treatment lines, and a text box highlights median recovery times for sugammadex, neostigmine, and rocuronium plus based on product-limit estimates.*

FDA Label Image

Figure (Sug02 0000 04)

A cumulative recovery rate graph depicting median and quartile ranges for sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time to recovery in minutes, illustrating faster recovery with sugammadex compared to neostigmine.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Sug02 0000 05)

Label for Sugammadex Injection, 200 mg per 2 mL (100 mg per mL) solution for intravenous use. The label states the product is supplied in a 2 mL single-dose vial and specifies to discard unused portions. It is manufactured for Sagent Pharmaceuticals and includes storage instructions to protect from light at 25°C (77°F).*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Sug02 0000 06)

The label for Sugammadex Injection shows a 5 mL single-dose vial containing 500 mg (100 mg/mL) of Sugammadex Sodium as an intravenous injection solution. The label indicates the solution is clear to slightly yellow-brown and is adjusted to pH 7-8. It is manufactured by Sagent Pharmaceuticals and includes dosage and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.